Related Experiment Video
Updated: May 9, 2026
10:11
Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
Rosacea and cardiovascular risk factors: a case control study
N Duman1, S Ersoy Evans, N Atakan
1Department of Dermatology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Summary
Patients with rosacea, an inflammatory skin condition, show a higher risk for cardiovascular disease (CVD). This suggests closer monitoring of rosacea patients for potential heart health issues is warranted.
Area of Science:
- Dermatology
- Cardiology
- Inflammatory Diseases
Background:
- Rosacea is a chronic inflammatory skin condition.
- Cardiovascular disease (CVD) poses a significant health burden.
- The potential link between rosacea and CVD risk requires investigation.
Purpose of the Study:
- To investigate the association between rosacea and the risk of developing cardiovascular disease (CVD).
Main Methods:
- A case-control study involving 60 rosacea patients and 50 matched controls.
- Collection of demographic data, medical history, and cardiovascular risk factors.
- Measurement of anthropometric data and comprehensive laboratory investigations including lipid profiles and C-reactive protein (CRP).
Main Results:
- Rosacea patients exhibited significantly higher levels of total cholesterol, low-density lipoprotein (LDL), and CRP compared to controls.
- A family history of premature CVD, smoking, and alcohol consumption were more prevalent in the rosacea group.
- The mean age of participants was approximately 44 years, with 66% being female in both groups.
Conclusions:
- Rosacea patients may be at an elevated risk for cardiovascular disease (CVD).
- Close monitoring of cardiovascular health in rosacea patients is recommended.
- Further randomized controlled studies are needed to elucidate the underlying mechanisms of this association.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:27Psychoneuroimmunology: Cardiovascular Disease
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...